ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 78 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q4 2017. The put-call ratio across all filers is 0.37 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $515,797 | -70.9% | 19,196 | -61.4% | 0.00% | -80.0% |
Q2 2023 | $1,773,514 | -63.8% | 49,734 | -74.2% | 0.01% | -75.0% |
Q1 2023 | $4,894,224 | +1843.4% | 192,686 | +3003.3% | 0.02% | +1900.0% |
Q4 2022 | $251,837 | +5.4% | 6,209 | -14.0% | 0.00% | 0.0% |
Q3 2022 | $239,000 | -95.0% | 7,223 | -94.7% | 0.00% | -96.3% |
Q2 2022 | $4,799,000 | +427.4% | 136,295 | +588.6% | 0.03% | +575.0% |
Q1 2022 | $910,000 | +109.2% | 19,793 | +184.3% | 0.00% | +300.0% |
Q3 2021 | $435,000 | -15.7% | 6,961 | +11.8% | 0.00% | -50.0% |
Q2 2021 | $516,000 | -43.3% | 6,229 | -70.5% | 0.00% | -83.3% |
Q3 2020 | $910,000 | -16.0% | 21,134 | -15.7% | 0.01% | -33.3% |
Q2 2020 | $1,083,000 | -44.7% | 25,072 | -63.1% | 0.02% | -64.0% |
Q1 2020 | $1,957,000 | +353.0% | 68,020 | +898.7% | 0.05% | +1566.7% |
Q4 2019 | $432,000 | +14.6% | 6,811 | -49.1% | 0.00% | 0.0% |
Q3 2019 | $377,000 | -36.9% | 13,385 | -40.5% | 0.00% | -50.0% |
Q2 2019 | $597,000 | -64.1% | 22,510 | -75.2% | 0.01% | -66.7% |
Q1 2019 | $1,664,000 | +740.4% | 90,654 | +468.4% | 0.02% | +800.0% |
Q4 2018 | $198,000 | +5.3% | 15,949 | -68.8% | 0.00% | -33.3% |
Q4 2017 | $188,000 | +164.8% | 51,200 | +212.2% | 0.00% | +200.0% |
Q3 2017 | $71,000 | +44.9% | 16,400 | -46.0% | 0.00% | 0.0% |
Q2 2017 | $49,000 | +63.3% | 30,398 | +57.2% | 0.00% | 0.0% |
Q4 2016 | $30,000 | – | 19,340 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Western Financial Corp/CA | 820,320 | $33,272,179 | 21.56% |
Aquilo Capital Management, LLC | 1,103,515 | $44,758,568 | 16.81% |
M28 Capital Management LP | 143,900 | $5,836,584 | 5.56% |
WEALTH EFFECTS LLC | 155,620 | $6,311,951 | 3.60% |
Evolutionary Tree Capital Management, LLC | 92,095 | $3,735,373 | 3.59% |
Privium Fund Management B.V. | 221,015 | $8,867,122 | 3.36% |
JOHNSON & JOHNSON | 247,598 | $10,043 | 2.92% |
COMMODORE CAPITAL LP | 462,111 | $18,743 | 2.82% |
Avidity Partners Management LP | 1,375,000 | $55,770,000 | 1.21% |
Capital Impact Advisors, LLC | 26,853 | $1,089,158 | 1.06% |